External radiotherapy versus vaginal brachytherapy for patients with intermediate risk endometrial cancer

Gynecologic Oncology

Volumn 106, Issue 1, 2007, Pages 215-220

  Lin, Lilie L ^a,b   Mutch, David G ^a,b   Rader, Janet S ^a,b   Powell, Matthew A ^a,b   Grigsby, Perry W ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b USA   (United States)

Author keywords

Brachytherapy; Endometrial carcinoma; External radiation

Indexed keywords

ABDOMINAL HYSTERECTOMY; ADULT; AGED; ARTICLE; ASCITES FLUID CYTOLOGY; BRACHYTHERAPY; CANCER PATIENT; CANCER RISK; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; ENDOMETRIUM CANCER; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HUMAN; INTERMETHOD COMPARISON; PELVIS LYMPHADENECTOMY; PRIORITY JOURNAL; SALPINGOOOPHORECTOMY; UNITED STATES;

EID: 34250159098     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2007.03.024     Document Type: Article

References (29)

1. Jemal A., Siegel R., Ward E., Murray T., Xu J., Smigal C., et al. Cancer Statistics, 2006. CA Cancer J. Clin. 56 2 (2006 (March 1)) 106-130
2. Trimble E.L., Harlan L.C., Clegg L.X., and Stevens J.L. Pre-operative imaging, surgery and adjuvant therapy for women diagnosed with cancer of the corpus uteri in community practice in the United States. Gynecol. Oncol. 96 3 (2005) 741-748
3. Keys H.M., Roberts J.A., Brunetto V.L., Zaino R.J., Spirtos N.M., Bloss J.D., et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol. Oncol. 92 3 (2004) 744-751
4. Creutzberg C.L., van Putten W.L., Koper P.C., Lybeert M.L., Jobsen J.J., Warlam-Rodenhuis C.C., et al. Survival after relapse in patients with endometrial cancer: results from a randomized trial. Gynecol. Oncol. 89 2 (2003) 201-209
5. Aalders J., Abeler V., and Kolstad P. Recurrent adenocarcinoma of the endometrium: a clinical and histopathological study of 379 patients. Gynecol. Oncol. 17 (1984) 85
6. Jolly S., Vargas C., Kumar T., Weiner S., Brabbins D., Chen P., et al. Vaginal brachytherapy alone: an alternative to adjuvant whole pelvis radiation for early stage endometrial cancer. Gynecol. Oncol. 97 3 (2005) 887-892
7. Ng T.Y., Perrin L.C., Nicklin J.L., Cheuk R., and Crandon A.J. Local recurrence in high-risk node-negative stage I endometrial carcinoma treated with postoperative vaginal vault brachytherapy. Gynecol. Oncol. 79 3 (2000) 490-494
8. Petereit D.G., Tannehill S.P., Grosen E.A., Hartenbach E.M., and Schink J.C. Outpatient vaginal cuff brachytherapy for endometrial cancer. Int. J. Gynecol. Cancer 9 6 (1999) 456-462
9. Chadha M., Nanavati P.J., Liu P., Fanning J., and Jacobs A. Patterns of failure in endometrial carcinoma stage IB grade 3 and IC patients treated with postoperative vaginal vault brachytherapy. Gynecol. Oncol. 75 1 (1999) 103-107
10. Fayed A., Mutch D.G., Rader J.S., Gibb R.K., Powell M.A., Wright J.D., et al. Comparison of high-dose-rate and low-dose-rate brachytherapy in the treatment of endometrial carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 67 2 (2007 (February 1)) 480-484
11. Creutzberg C.L., van Putten W.L., Koper P.C., Lybeert M.L., Jobsen J.J., Warlam-Rodenhuis C.C., et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet 355 9213 (2000) 1404-1411
12. Kaplan E.L., and Meier P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53 (1958) 457-481
13. Cox D.R. Regression models and life tables. J. R. Stat. Soc. 34 (1972) 187-220
14. Aalders J., Abeler V., Kolstad P., and Onsrud M. Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients. Obstet. Gynecol. 56 4 (1980) 419-427
15. Lin L.L., Grigsby P.W., Powell M.A., and Mutch D.G. Definitive radiotherapy in the management of isolated vaginal recurrences of endometrial cancer. Int. J. Radiat. Oncol. Biol. Phys. 63 2 (2005/10/1) 500-504
16. Creutzberg C.L., van Putten W.L., Koper P.C., Lybeert M.L., Jobsen J.J., Warlam-Rodenhuis C.C., et al. The morbidity of treatment for patients with stage I endometrial cancer: results from a randomized trial. Int. J. Radiat. Oncol. Biol. Phys. 51 5 (2001) 1246-1255
17. Horowitz N.S., Peters W.A., Smith M.R., Drescher C.W., Atwood M., and Mate T.P. Adjuvant high dose rate vaginal brachytherapy as treatment of stage I and II endometrial carcinoma. Obstet. Gynecol. 99 2 (2002) 235-240
18. Solhjem M.C., Petersen I.A., and Haddock M.G. Vaginal brachytherapy alone is sufficient adjuvant treatment of surgical stage I endometrial cancer. Int. J. Radiat. Oncol. Biol. Phys. 62 5 (2005) 1379-1384
19. Alektiar K.M., Venkatraman E., and Barakat R.R. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer. Int. J. Radiat. Oncol. Biol. Phys. 62 1 (2005 (May 1)) 111-117
20. Cengiz M., Singh A.K., and Grigsby P.W. Postoperative vaginal brachytherapy alone is the treatment of choice for grade 1-2, stage IC endometrial cancer. Int. J. Gynecol. Cancer 15 5 (2005) 926-931
21. Mariani A., Webb M.J., Keeney G.L., Lesnick T.G., and Podratz K.C. Surgical stage I endometrial cancer: predictors of distant failure and death. Gynecol. Oncol. 87 3 (2002) 274-280
22. Descamps P., Calais G., Moire C., Bertrand P., Castiel M., Le Floch O., et al. Predictors of distant recurrence in clinical stage I or II endometrial carcinoma treated by combination surgical and radiation therapy. Gynecol. Oncol. 64 1 (1997) 54-58
23. Lanciano R.M., Corn B.W., Schultz D.J., Kramer C.A., Rosenblum N., and Hogan W.M. The justification for a surgical staging system in endometrial carcinoma. Radiother. Oncol. 28 3 (1993) 189-196
24. Mayr N.A., Wen B.C., Benda J.A., Sorosky J.I., Davis C.S., Fuller R.W., et al. Postoperative radiation therapy in clinical stage I endometrial cancer: corpus, cervical, and lower uterine segment involvement-Patterns of failure. Radiology 196 2 (1995) 323-328
25. Inoue Y., Obata K., Abe K., Ohmura G., Doh K., Yoshioka T., et al. The prognostic significance of vascular invasion by endometrial carcinoma. Cancer 78 7 (1996) 1447-1451
26. DiSaia P.J., Creasman W.T., Boronow R.C., and Blessing J.A. Risk factors and recurrent patterns in Stage I endometrial cancer. Am. J. Obstet. Gynecol. 151 8 (1985) 1009-1015
27. Mariani A., Sebo T.J., Webb M.J., Riehle D., Katzmann J.A., Keeney G.L., et al. Molecular and histopathologic predictors of distant failure in endometrial cancer. Cancer Detect. Prev. 27 6 (2003) 434-441
28. Fanning J. Long-term survival of intermediate risk endometrial cancer (stage IG3, IC, II) treated with full lymphadenectomy and brachytherapy without teletherapy. Gynecol. Oncol. 82 2 (2001) 371-374
29. Rittenberg P.V., Lotocki R.J., Heywood M.S., Jones K.D., and Krepart G.V. High-risk surgical stage 1 endometrial cancer: outcomes with vault brachytherapy alone. Gynecol. Oncol. 89 2 (2003 (May)) 288-294